Zenas BioPharma, Inc. (ZBIO)
21.74
+0.69
(+3.28%)
USD |
NASDAQ |
Apr 16, 16:00
21.74
0.00 (0.00%)
After-Hours: 18:10
Zenas BioPharma Market Cap : 1.356B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 2.560B |
| AnaptysBio, Inc. | 1.923B |
| Gilead Sciences, Inc. | 171.97B |
| Nkarta, Inc. | 199.61M |
| Cullinan Therapeutics, Inc. | 891.55M |
Market Cap Related Metrics
| PS Ratio | 93.66 |
| PEG Ratio | -0.0221 |
| Price to Book Value | 5.599 |
| Price | 21.74 |
| Earnings Yield | -38.84% |
| PEGY Ratio | -0.0221 |